Name: Will RFK end any vaccine approvals by December 31?
Start: 2025-09-04T03:38:01.444089Z
End: 2025-12-31T00:00:00Z

Use the internal polymarket geolocation service.

poly_geo

Improved notification preferences and types.

notifications_v2

funkit_deposit

funkit_withdraw

authenticated_book_ws

Improved in-game view for sports markets.

mobile_sports_overlay_v2

async_order_submission

Enable updates from the sports websocket.

sports_websocket

Show/hide language selector in navigation

language_selector

Auto-detect and redirect based on browser language

auto_locale_detection

This market will resolve to "Yes" if any vaccine has its Biologics License Application (BLA) approval or Emergency Use Authorization (EUA) revoked by the FDA or is voluntarily withdrawn for reasons related to health, safety, or efficacy by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”. 

Withdrawing approval solely due to seasonality, low demand, or an emergency ending will not be sufficient for a "Yes" resolution. Similarly, a reduction in the scope of approved recipients, without fully eliminating the approval will not be sufficient for a "Yes" resolution."

The resolution source will be official FDA announcements and guidance published on the FDA website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).

Will RFK end any vaccine approvals by December 31?

Retatrutide is a triple agonist hormone/peptide drug developed by Eli Lilly and currently in trial to treat obesity, fatty liver disease, type-2 diabetes, knee osteoarthritis, and more.

This market will resolve to "Yes" if the U.S. Food and Drug Administration (FDA) grants a full or conditional approval for Eli Lilly’s for a drug product whose active ingredient is Eli Lilly’s retatrutide (including any brand name or identifier such as LY3437943) for any use between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No."

An approval is defined as:
For new drugs: FDA issuance of an approval letter for a New Drug Application (NDA) or Biologics License Application (BLA)
For already-marketed drugs seeking new indications: FDA approval of a supplemental NDA (sNDA) or supplemental BLA (sBLA) for the specific indication referenced
For generic drugs: FDA approval of an Abbreviated New Drug Application (ANDA)
For biosimilars: FDA approval of a 351(k) application

The following constitute qualifying approvals:
Standard approval (traditional approval based on clinical benefit), Accelerated approval (based on surrogate endpoints), Approval with Risk Evaluation and Mitigation Strategy (REMS), Approval with restricted distribution or indication limitations, except compassionate use/expanded access programs

The following do not constitute qualifying approvals:
Approvable letters that require additional actions before approval
Tentative approvals pending patent or exclusivity expiration
FDA requests for additional information or studies
Extension of Prescription Drug User Fee Amendments dates
Approval for compassionate use or expanded access programs only
Approval only for export or for use outside the United States
Emergency Use Authorization (EUA) without full approval
Complete Response Letters (CRLs) indicating the application cannot be approved in its current form

If the listed drug is approved within this market’s timeframe, the market will resolve to "Yes," regardless of potential Advisory Committee votes against approval or later withdrawal of approval.

Conditional approvals may include post-marketing requirements or commitments and still qualify.

The primary resolution source will be official information from the FDA; however, a consensus of credible reporting will also be used.

Wird Retatrutide dieses Jahr von der FDA zugelassen?

This market will resolve to "Yes" if the CDC identifies a new COVID variant of concern between December 1, 2025, and December 31, 2026, 11:59PM ET. Otherwise this market will resolve to "No".

The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.

The resolution source for this market will be official information from the CDC.

Neue besorgniserregende COVID-Variante vor 2027?

TrumpRx (https://trumprx.gov/) is scheduled to launch in January 2026 and is intended to help consumers access lower-cost medications by directing them to manufacturers’ direct-to-consumer purchasing channels.

This market will resolve to "Yes" if TrumpRx.gov becomes publicly accessible in a form that allows members of the public to search for and find medications by January 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No."

To qualify, the site must be publicly accessible and operational in at least a limited capacity, meaning it functions in its intended portal role by allowing users to search for or view medications and be redirected to purchase them. Glitches or minor technical issues will not render the site non-functional, provided the core portal functionality remains available to the public.

Once the qualifying functionality goes live, the market will resolve to "Yes" immediately, regardless of any subsequent reversal, rollback, or withdrawal of access.

This market will resolve to "No" if TrumpRx.gov becomes permanently unavailable.

The primary resolution source for this market will be TrumpRx.gov; however, a consensus of credible reporting will also be used.

TrumpRX bis zum 31. Januar 2026 eingeführt?

This market will resolve to "Yes" if an official agreement on nuclear arms control or strategic nuclear weapons limitation is reached between the United States and the Russian Federation between December 9, 2025 and June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.

Only agreements that are publicly announced and acknowledged by both the U.S. and Russia will qualify. The agreement must pertain to nuclear arms control or limitation—such as a treaty, framework, or memorandum—addressing matters including (but not limited to) nuclear warheads, delivery systems, verification mechanisms, or strategic stability.

An extension, amendment, or replacement of the New START treaty will qualify, provided it is publicly announced as a concluded agreement by both parties within the time frame. Exploratory discussions or stated intent to extend without a finalized agreement will not qualify.

Agreements that include both the United States and Russia as named parties—whether bilateral or as part of a broader multilateral framework—will qualify, provided the agreement directly addresses nuclear arms control.

The agreement does not need to be ratified or implemented for this market to resolve "Yes"; a formal announcement of a concluded agreement is sufficient.

The primary resolution source for this market will be official statements from the U.S. government (e.g., the White House, State Department) and/or the Russian Federation (e.g., the Kremlin, Ministry of Foreign Affairs). However, a clear and overwhelming consensus of credible reporting confirming that such an agreement has been reached will also qualify.

USA x Russland Atomabkommen bis zum 30. Juni?

This market will resolve to “Yes” if credible reporting confirms that any entity enters into an agreement to acquire the listed company by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.

Mergers where the listed company is subsumed by another entity will count toward a "Yes" resolution.

An announced agreement between the listed company and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.

The primary resolution source for this market is official information from the listed company and/or its leadership; however, a consensus of credible reporting will also be used.

Wird Ubisoft vor 2027 übernommen?

This market will resolve to “Yes” if the upper bound of the target federal funds rate is decreased at any point between December 16, 2025 and the completion of the Federal Open Market Committee (FOMC) meeting for June 2026, currently scheduled for June 16-17. Otherwise, this market will resolve to “No”.

If no June meeting takes place by July 7, 2026, 11:59 PM ET, and no qualifying rate cut has been announced, this market will resolve to "No". 

Emergency rate cuts will qualify.

The primary resolution source for this market will be the official website of the Federal Reserve (https://www.federalreserve.gov/monetarypolicy/openmarket.htm), however a consensus of credible reporting may also be used.

Fed-Zinssenkung bis zur Sitzung im Juni 2026?

This market will resolve to "Yes" if President of the United States Donald Trump announces he has resigned or will resign the presidency by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No."

If it becomes impossible for Donald Trump to resign or to announce his resignation (e.g., due to his removal from office by other means, etc.), this market will immediately resolve to "No."

For this market to resolve to "Yes," it is only necessary that Trump announce that he has resigned or will resign. Whether he actually resigns will have no bearing on the resolution of this market.

The primary resolution source for this market will be official information from the US federal government; however, a consensus of credible reporting will also be used.

Wird Trump bis zum 31. Dezember 2026 zurücktreten?

This market will resolve to "Yes" if Felix Protocol officially launches a token by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The token must be actively and publicly transferable and tradable. Announcements alone do not qualify

The primary resolution source for this market will be information from Felix Protocol, however a consensus of credible reporting will also be used.


Wird Felix Protocol bis zum 31. Dezember 2026 einen Token herausbringen?

This market will resolve to “Yes” if the European Union (EU) dissolves by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.

The European Union will be considered to be dissolved if any of the following conditions are met:

1) More than half of the EU member states (as of market creation) formally withdraw from the EU.

2) An official treaty or agreement is adopted between all EU member states to repeal or nullify the Treaty on European Union or the Treaty on the Functioning of the European Union.
 
3) The European Union otherwise ceases to exist as a legal entity.

EU member states will be considered to have withdrawn once they officially initiate their withdrawal and/or formally notify the European Council of their intention to withdraw, regardless of whether the withdrawal is finalized after this market’s timeframe.

The primary resolution source for this market will be official information from the European Union and EU member states; however, a consensus of credible reporting may also be used.

Zerfällt die EU vor 2027?

Will fomo.family be acquired in 2026?

This market will resolve to “Yes” if the upper bound of the target federal funds rate is increased at any point between January 1, 2026 and the Fed's December 2026 meeting, currently scheduled for December 8-9, 2026. Otherwise, this market will resolve to “No”.

This market may not resolve to "No" until the Fed has released its rate change decision following its December meeting.

The primary resolution source for this market will be the official website of the Federal Reserve (https://www.federalreserve.gov/monetarypolicy/openmarket.htm), however a consensus of credible reporting may also be used.

Fed-Zinserhöhung im Jahr 2026?

This market will resolve to "Yes" if Nikita Bier ceases to be Head of Product of X for any length of time between market creation and March 31, 2026, 11:59PM ET. Otherwise, this market will resolve to "No".

An announcement of Nikita Bier's resignation/firing before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/firing goes into effect.

This market's primary resolution source will be official information from X and/or Nikita Bier, however a consensus of credible reporting will also be used.

Nikita Bier bis spätestens 31. März nicht mehr Head of Product bei X?

This market will resolve to “Yes” if Kristi Noem ceases to be the Secretary of Homeland Security for any period of time between market creation and March 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.

An announcement of Noem's resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.

The resolution source for this market will be official information from the Trump administration, however a consensus of credible reporting may also be used.

Kristi Noem bis zum 31. März raus?

This market will resolve to "Yes" if the Supreme Court of the United States issues a decision that reverses, vacates, or otherwise overturns the U.S. Court of Appeals for the Federal Circuit’s August 29, 2025 decision in V.O.S. Selections, Inc. v. Trump, in which the Federal Circuit held that the tariffs imposed by Executive Orders 14193, 14194, 14195, 14257, and 14266 exceeded the President’s authority under the International Emergency Economic Powers Act (IEEPA) by December 2026, 11:59 PM ET. Otherwise this market will resolve to "No." 

If the Supreme Court dismisses the case as improvidently granted, denies certiorari, grants/vacates/remands without deciding the merits of IEEPA authorization, affirms by an equally divided Court, or vacates due to mootness, or if the parties settle the case this market will resolve to "No." 

For purposes of this market, the government prevails if the Supreme Court rules on the merits that the tariffs are authorized under IEEPA, or otherwise reverses or vacates the Federal Circuit’s holding that they are unauthorized under IEEPA, regardless of whether the Court remands for further proceedings on issues such as remedy or scope of relief. The government does not prevail if the Supreme Court affirms the Federal Circuit’s decision that the tariffs are unauthorized by IEEPA, even if the Court modifies or vacates portions of the judgment relating only to remedy or injunctive relief.

The resolution source will be a consensus of credible reporting. 


Der Oberste Gerichtshof entscheidet zugunsten von Trumps Zöllen?

This market will resolve to "Yes" if at least one cabinet-level Donald Trump appointee from his second term leaves their position by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

Voluntary resignations, removals, retirements, or departures for any reason will count.

Announcements alone will not qualify toward this market's resolution. An individual must actually have left their cabinet-level position.

Temporary or acting officials will not count toward this market's resolution.

The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.

Bis zum 31. Dezember 2026 ein Mitglied von Trumps Kabinett nicht mehr im Amt?

This market will resolve to "Yes" if the Bureau of Labor Statistics fails to release any monthly report on the Consumer Price Index by 11:59PM ET on the scheduled release date between December 1, 2025 and December 31, 2026, 11:59PM ET. Otherwise, this market will resolve to "No".

If an announcement is made by the White House or the BLS that the monthly CPI release will be delayed or cancelled altogether, this market will immediately resolve to "Yes".

The resolution source for this market will be information from the BLS or a consensus of credible reporting. 

BLS verzögert eine weitere Veröffentlichung des Verbraucherpreisindex vor 2027?

This market will resolve to "Yes" if Base officially launches a token by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The token must be actively and publicly transferable and tradable. Announcements alone do not qualify

The primary resolution source for this market will be information from Base, however a consensus of credible reporting will also be used.


Wird Base bis zum 31. Dezember 2026 einen Token launchen?

The FED interest rates are defined in this market by the lower or the upper bound of the target federal funds range. The decisions on the target federal fund range are made by the Federal Open Market Committee (FOMC) meetings.

This market will resolve to “Yes” if the lower or the upper bound of the target federal funds rate reaches the specified level at any point by December 31, 2026, 12:59 PM ET. Otherwise, this market will resolve to “No.”

Emergency rate cuts and hikes outside the regularly scheduled meetings will be considered.

The resolution source for this market is the official website of the Federal Reserve at:
https://www.federalreserve.gov/monetarypolicy/openmarket.htm.

This market may resolve as soon as the relevant data showing the reached level is published.

Wird die Untergrenze der Fed vor 2027 3,25 % oder weniger erreichen?

This market will resolve to "Yes" if a U.S government funding lapse occurs on January 31, 2026, 12:00 AM ET. Otherwise, this market will resolve to "No".

A funding lapse is defined as the President failing to sign the relevant bill(s) extending government funding by January 30, 2026, 11:59 PM ET. If a bill extending the funding of the U.S. government is passed and signed by the acting President before January 31, 2026, 12:00 AM ET, this market will resolve to "No".

For this market to resolve to "Yes," any funding lapse will count. If only a portion of the US government is covered by any signed bill(s) extending funding of the US government, and a portion of the US government goes unfunded, this market will still resolve to "Yes".

The primary resolution for this source will be official information from the US government, however a consensus of credible reporting may also be used.

Stillstand der US-Regierungsfinanzierung am 31. Januar?

The CDC reported a general fertility rate of 53.7 births per 1,000 women aged 15–44 for Q2 2025 (see: https://www.cdc.gov/nchs/nvss/vsrr/natality-dashboard.htm). 

This market will resolve to "Yes" if the initial reported rate for Q3 2025 exceeds 53.7, according to the CDC's Vital Statistics Rapid Release series. Otherwise, this market will resolve to "No". 

If the CDC does not release general fertility rate data for Q3 2025 by March 31, 2026, 11:59 PM ET, this market will resolve to "No".

Resolution will be based on the first published estimate for Q3 2025, regardless of any subsequent revisions.

The resolution source will be the CDC’s Vital Statistics Rapid Release.

US-Fruchtbarkeitsrate im 3. Quartal 2025 gestiegen?

This market will resolve to "Yes" if the 2026 US Midterm Elections happen on November 3, 2026. Otherwise, this market will resolve to "No".

The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.

Werden die Zwischenwahlen 2026 wie geplant stattfinden?

This market will resolve to “Yes” if any European Union (EU) member state withdraws from the EU by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.

An EU member state will be considered to have withdrawn once they officially initiate their withdrawal and/or formally notify the European Council of their intention to withdraw, regardless of whether the withdrawal is finalized after this market’s timeframe.

The primary resolution source for this market will be official information from the European Union and EU member states; however, a consensus of credible reporting may also be used.

Tritt ein Land vor 2027 aus der EU aus?

This market will resolve to “Yes” if Rabby officially launches a governance token by 11:59 PM ET on the date specified in the title. Otherwise, this market will resolve to “No”.

The token must be actively and publicly transferable and tradable. Announcements alone do not qualify.

The primary resolution source for this market will be information from Rabby, however a consensus of credible reporting will also be used.

Will Rabby launch a token by December 31, 2026?

This market will resolve to "Yes" if any country named in President Donald Trump’s December 16, 2025, proclamation titled “Restricting and Limiting the Entry of Foreign Nationals to Protect the Security of the United States” is fully removed from the list of countries subject to full or partial entry suspensions by January 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

A country will be considered "removed" if any of the following occur:
- The President or Executive Branch formally revokes or modifies the proclamation to remove the country
- A federal court issues a final ruling or permanent injunction that blocks the restrictions for that country
- Congress passes legislation lifting the restrictions for that country
- A relevant federal agency (e.g., DHS, State Department) issues official guidance or updates visa policy indicating the country is no longer subject to restrictions
- Nationals of the country resume receiving visas under all categories that had been suspended, without case-by-case waivers

The following do not count as a country being removed:
- Temporary restraining orders or preliminary injunctions (unless later made permanent)
- Delays in enforcement, individual exemptions, or case-by-case waivers
- Diplomatic negotiations or public statements about potential future removal without official action
- Partial easing that still imposes core restrictions (e.g., resuming B-1/B-2 visas while immigrant visas remain banned)

Any official executive, legislative, or judicial action that prevents the proclamation from taking effect on January 1, 2026, or that pauses or ends the travel ban or restriction of a specified country will suffice. 

The resolution source for this market will be a consensus of credible reporting and official government communications.

Wird Trumps Einreiseverbot bis zum 31. Januar aufgehoben?

This market will resolve based on the next earnings announcement of EA currently scheduled to take place on February 3, 2026 at 11:59 PM EST.

This market will resolve to "Yes" if the listed term is mentioned by anyone during this event. Otherwise, the market will resolve to "No".

Any usage of the term, regardless of context, will count toward the resolution of this market.

Pluralization/possessive of the term will count toward the resolution of this market; however, other forms will NOT count.

Instances where the term is used in a compound word will count regardless of context (e.g. joyful is not a compound word for "joy," however "killjoy" is a compounding of the words "kill" and "joy").

If this market requires a specified number of mentions of a person’s first or last name, a full-name mention will count as one mention (e.g., if a market is about “Joe / Biden 5+ times,” a mention of “Joe Biden” will count once).

A Q&A event will count toward the resolution of this market.

If this event is definitely cancelled, or otherwise is not aired by March 31, 2026, 11:59 PM ET, this market will resolve to "No".

The resolution source will be audio of the event.

Will EA say "Mobile" during earnings call?

This market will resolve to “Yes” if the Supreme Court, in Trump v. Slaughter, rules to overturn Humphrey's Executor v. United States by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.

The Supreme Court will be considered to overturn Humphrey's Executor v. United States if they issue a decision in Trump v. Slaughter overruling or substantially limiting Humphrey's Executor v. United States (1935), including ruling that the President may remove FTC commissioners at will.

If the Supreme court ruling in Trump v. Slaughter affirms that for-cause removal protections for FTC commissioners remain constitutional or if the case is dismissed, settled, or otherwise disposed of without a merits decision within this market’s timeframe, the market will resolve to “No”. If no Supreme Court ruling on the merits of Trump v. Slaughter is issued by December 31, 2026, 11:59 PM ET, this market will resolve to “No”.

The resolution source for this market will be official information from the U.S. Supreme Court; however, a consensus of credible reporting will also be used.

Will RFK end any vaccine approvals by December 31?

Marktkontext

Will RFK end any vaccine approvals by December 31?

Regeln

Will RFK end any vaccine approvals by December 31?

Marktkontext

Will RFK end any vaccine approvals by December 31?

Über